Elevance Health Inc. (ELV) Balance Sheet
ELV balance sheet, 2025
December 31, 2025 · U.S. dollars$121.49B assets = $77.47B liabilities + $44.03B equity
Both columns are drawn to the same scale: what ELV owns equals what it owes plus shareholders’ equity. Hover a block for its value.
ELV financial health
Current ratio1.24
Adequate · current assets cover current liabilities 1.24×
Debt / equity0.76
Moderate leverage · $0.76 of debt for each $1 of equity
Equity / assets36.1%
Balanced · of assets funded by shareholders
Cash / debt28.6%
Low cash cover · cash & short-term investments vs total debt
Goodwill & intangibles32.5%
Acquisition-heavy · of total assets
Descriptive bands, not a rating. Fiscal 2025.
ELV balance sheet trends, 2016–2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $66.39B2016 | $121.49B2025 | +6.9%/yr | |
| Total liabilities | $41.29B2016 | $77.47B2025 | +7.2%/yr | |
| Shareholders’ equity | $25.10B2016 | $43.88B2025 | +6.4%/yr | |
| Cash & short-term investments | $4.08B2016 | $9.49B2025 | +9.8%/yr | |
| Total debt | $15.73B2016 | $33.23B2025 | +8.7%/yr | |
| Net cash (debt) | −$11.65B2016 | −$23.74B2025 | −$12.1B | |
| Working capital | $675.1M2016 | $4.77B2025 | +$4.1B | |
| Book value per share | $93.622016 | $197.842025 | +8.7%/yr | |
| Current ratio | 1.072016 | 1.242025 | +0.17 | |
| Debt / equity | 0.632016 | 0.762025 | +0.13 | |
| Shares outstanding | 268.1M2016 | 221.8M2025 | −2.1%/yr |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
ELV assets
Cash & ST investmentsReceivablesInventoryOther currentPP&EGoodwill & intangiblesLT investmentsOther non-current
ELV liabilities and equity
Current liabilitiesLong-term debtOther long-term liabilitiesEquity
ELV debt vs cash
Total debtCash & ST investmentsNet cash (debt)
Debt includes short- and long-term borrowings and, where reported, lease obligations.
ELV balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & short-term investments | $9.49B | $8.29B | $6.53B | $7.39B | $4.88B | $5.74B | $4.94B | $3.93B | $3.61B | $4.08B |
| Cash & equivalents | $9.49B | $8.29B | $6.53B | $7.39B | $4.88B | $5.74B | $4.94B | $3.93B | $3.61B | $4.08B |
| Short-term investments | $25.88B | $25.20B | $29.61B | $25.95B | $26.27B | $23.43B | $19.68B | $16.71B | $17.39B | $17.18B |
| Receivables | $15.23B | $13.05B | $12.46B | $11.75B | $9.69B | $8.13B | $7.58B | $6.74B | $6.18B | $5.86B |
| Inventory | $0 | $0 | −$46.33B | −$11.38B | −$38.48B | −$34.33B | −$29.05B | −$25.55B | −$36.26B | −$34.31B |
| Other current assets | $0 | $0 | $46.33B | $11.38B | $38.48B | $34.33B | $29.05B | $25.55B | $36.26B | $34.31B |
| Total current assets | $24.73B | $21.34B | $18.99B | $19.13B | $14.57B | $13.87B | $12.52B | $10.68B | $9.79B | $9.94B |
| Property, plant & equipment (net) | $5.13B | $5.22B | $4.94B | $4.92B | $4.55B | $4.13B | $3.71B | $2.73B | $2.17B | $1.98B |
| Goodwill & intangible assets | $39.54B | $40.37B | $35.59B | $34.70B | $34.84B | $31.10B | $29.17B | $29.51B | $27.60B | $25.53B |
| Long-term investments | $27.75B | $27.43B | $30.72B | $27.66B | $28.78B | $4.85B | $4.73B | $4.21B | $3.94B | $2.80B |
| Other non-current assets | $24.35B | $22.53B | $18.69B | $16.35B | $14.72B | $34.34B | $28.12B | $25.33B | $27.95B | $26.15B |
| Total assets | $121.49B | $116.89B | $108.93B | $102.75B | $97.46B | $88.28B | $78.25B | $72.47B | $71.46B | $66.39B |
| Liabilities | ||||||||||
| Accounts payable | $17.08B | $15.75B | $16.11B | $15.60B | $13.52B | $11.36B | $8.84B | $7.45B | $7.99B | $7.89B |
| Short-term debt | $1.38B | $2.17B | $2.04B | $1.95B | $2.01B | $810.0M | $2.46B | $1.99B | $2.55B | $1.37B |
| Deferred revenue | $1.49B | $1.51B | $1.40B | $1.11B | $1.15B | $1.26B | $1.02B | $902.0M | $860.0M | $971.9M |
| Total current liabilities | $19.96B | $19.42B | $19.55B | $18.65B | $15.53B | $12.17B | $11.30B | $9.45B | $10.54B | $9.26B |
| Long-term debt | $30.80B | $29.22B | $23.25B | $22.35B | $21.16B | $19.34B | $17.79B | $17.22B | $17.38B | $14.36B |
| Other long-term liabilities | $26.71B | $26.82B | $26.73B | $25.42B | $24.65B | $23.57B | $17.44B | $17.26B | $17.03B | $17.67B |
| Total liabilities | $77.47B | $75.46B | $69.52B | $66.42B | $61.33B | $55.08B | $46.53B | $43.93B | $44.96B | $41.29B |
| Shareholders' equity | ||||||||||
| Common stock & paid-in capital | $2.0M | $2.0M | $2.0M | $2.0M | $2.0M | $3.0M | $3.0M | $3.0M | $2.6M | $2.6M |
| Retained earnings (deficit) | $35.39B | $33.55B | $31.75B | $29.65B | $27.09B | $23.80B | $22.57B | $19.99B | $18.05B | $16.56B |
| Treasury stock | — | — | — | — | — | — | — | — | $0 | $0 |
| Accumulated other comprehensive income | −$451.0M | −$1.15B | −$1.31B | −$2.49B | −$178.0M | $150.0M | −$296.0M | −$986.0M | −$101.5M | −$267.9M |
| Minority interest | $144.0M | $111.0M | $99.0M | $87.0M | $68.0M | — | — | — | $0 | $0 |
| Total shareholders' equity | $43.88B | $41.31B | $39.31B | $36.24B | $36.06B | $33.20B | $31.73B | $28.54B | $26.50B | $25.10B |
| Key figures | ||||||||||
| Total debt | $33.23B | $32.70B | $26.65B | $25.80B | $24.89B | $21.84B | $21.21B | $19.21B | $19.93B | $15.73B |
| Net cash (debt) | −$23.74B | −$24.41B | −$20.13B | −$18.41B | −$20.01B | −$16.10B | −$16.27B | −$15.28B | −$16.32B | −$11.65B |
| Working capital | $4.77B | $1.92B | −$565.0M | $479.0M | −$954.0M | $1.70B | $1.22B | $1.23B | −$747.3M | $675.1M |
| Tangible book value | $4.34B | $944.0M | $3.72B | $1.54B | $1.22B | $2.10B | $2.55B | −$970.0M | −$1.10B | −$425.7M |
| Book value per share | $197.84 | $177.39 | $165.57 | $149.27 | $146.11 | $130.55 | $121.89 | $112.23 | $98.97 | $93.62 |
| Shares outstanding | 221.8M | 232.9M | 237.4M | 242.8M | 246.8M | 254.3M | 260.3M | 254.3M | 267.8M | 268.1M |
| Current ratio | 1.24 | 1.10 | 0.97 | 1.03 | 0.94 | 1.14 | 1.11 | 1.13 | 0.93 | 1.07 |
| Quick ratio | 1.24 | 1.10 | 0.97 | 1.03 | 0.94 | 1.14 | 1.11 | 1.13 | 0.93 | 1.07 |
| Debt / equity | 0.76 | 0.79 | 0.68 | 0.71 | 0.69 | 0.66 | 0.67 | 0.67 | 0.75 | 0.63 |
| Equity / assets | 36.1% | 35.3% | 36.1% | 35.3% | 37.0% | 37.6% | 40.5% | 39.4% | 37.1% | 37.8% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & short-term investments | $37.51B | $35.56B | $9.49B | $8.71B | $8.56B | $7.50B | $8.29B | $7.87B | $6.50B | $6.23B | $6.53B | $10.92B |
| Cash & equivalents | $10.23B | $9.66B | $9.49B | $8.71B | $8.56B | $7.50B | $8.29B | $7.87B | $6.50B | $6.23B | $6.53B | $10.92B |
| Short-term investments | $27.28B | $25.91B | $25.88B | $26.28B | $25.30B | $25.44B | $25.20B | $28.95B | $28.90B | $29.53B | $29.61B | $27.81B |
| Receivables | $23.39B | $22.79B | $15.23B | $14.66B | $15.92B | $15.61B | $13.05B | $12.34B | $13.34B | $13.17B | $12.46B | $11.64B |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | −$11.19B | −$17.68B | −$54.05B | −$54.01B | −$35.69B |
| Other current assets | $6.28B | $8.68B | $0 | $0 | $0 | $0 | $0 | $11.19B | $17.68B | $54.05B | $54.01B | $35.69B |
| Total current assets | $67.18B | $67.03B | $24.73B | $23.37B | $24.48B | $23.11B | $21.34B | $20.21B | $19.83B | $19.40B | $18.99B | $22.56B |
| Property, plant & equipment (net) | $4.64B | $4.66B | $5.13B | $4.66B | $4.64B | $4.62B | $5.22B | $4.50B | $4.45B | $4.45B | $4.94B | $4.82B |
| Goodwill & intangible assets | $39.32B | $39.43B | $39.54B | $39.78B | $39.86B | $40.36B | $40.37B | $36.29B | $36.41B | $36.66B | $35.59B | $35.78B |
| Long-term investments | $28.54B | $28.53B | $27.75B | $28.61B | $27.32B | $27.21B | $27.43B | $30.96B | $30.34B | $30.92B | $30.72B | $28.79B |
| Other non-current assets | $0 | $0 | $24.35B | $26.33B | $25.64B | $24.42B | $22.53B | $24.57B | $21.95B | $20.47B | $18.69B | $18.52B |
| Total assets | $126.44B | $125.83B | $121.49B | $122.75B | $121.94B | $119.72B | $116.89B | $116.53B | $112.99B | $111.89B | $108.93B | $110.48B |
| Liabilities | ||||||||||||
| Accounts payable | $25.09B | $6.21B | $17.08B | $17.15B | $17.16B | $16.81B | $15.75B | $15.35B | $15.20B | $16.46B | $16.11B | $16.18B |
| Short-term debt | $375.0M | $724.0M | $1.38B | $929.0M | $2.01B | $1.89B | $2.17B | $2.46B | $3.12B | $4.47B | $2.04B | $971.0M |
| Deferred revenue | $1.64B | $1.76B | $1.49B | $1.83B | $1.56B | $1.64B | $1.51B | $1.79B | $1.48B | $1.47B | $1.40B | $4.33B |
| Total current liabilities | $32.78B | $45.31B | $19.96B | $18.08B | $20.72B | $20.34B | $19.42B | $19.60B | $19.81B | $22.41B | $19.55B | $21.48B |
| Long-term debt | $30.67B | $30.77B | $30.80B | $31.17B | $28.18B | $28.11B | $29.22B | $24.69B | $24.56B | $21.98B | $23.25B | $24.05B |
| Other long-term liabilities | $17.97B | $5.71B | $26.71B | $29.42B | $29.18B | $28.64B | $26.82B | $28.37B | $26.32B | $26.80B | $26.73B | $26.41B |
| Total liabilities | $81.42B | $81.78B | $77.47B | $78.67B | $78.09B | $77.10B | $75.46B | $72.65B | $70.69B | $71.18B | $69.52B | $71.94B |
| Shareholders' equity | ||||||||||||
| Common stock & paid-in capital | $2.0M | $2.0M | $2.0M | $2.0M | $2.0M | $2.0M | $2.0M | $2.0M | $2.0M | $2.0M | $2.0M | $2.0M |
| Retained earnings (deficit) | $36.67B | $35.80B | $35.39B | $35.59B | $35.55B | $34.55B | $33.55B | $35.16B | $34.58B | $33.09B | $31.75B | $32.10B |
| Accumulated other comprehensive income | −$711.0M | −$741.0M | −$451.0M | −$543.0M | −$760.0M | −$911.0M | −$1.15B | −$489.0M | −$1.39B | −$1.36B | −$1.31B | −$2.51B |
| Minority interest | $139.0M | $140.0M | $144.0M | $129.0M | $129.0M | — | — | — | — | — | — | — |
| Total shareholders' equity | $44.88B | $43.90B | $43.88B | $43.95B | $43.72B | $42.50B | $41.31B | $43.77B | $42.19B | $40.61B | $39.31B | $38.42B |
| Key figures | ||||||||||||
| Total debt | $31.04B | $31.84B | $33.23B | $32.10B | $30.19B | $30.00B | $32.70B | $27.15B | $27.69B | $26.45B | $26.65B | $26.41B |
| Net cash (debt) | $6.47B | $3.72B | −$23.74B | −$23.39B | −$21.63B | −$22.50B | −$24.41B | −$19.28B | −$21.19B | −$20.23B | −$20.13B | −$15.49B |
| Working capital | $34.41B | $21.72B | $4.77B | $5.29B | $3.75B | $2.76B | $1.92B | $611.0M | $24.0M | −$3.01B | −$565.0M | $1.08B |
| Tangible book value | $5.56B | $4.47B | $4.34B | $4.17B | $3.86B | $2.14B | $944.0M | $7.48B | $5.78B | $3.95B | $3.72B | $2.64B |
| Book value per share | $205.98 | $199.19 | $197.84 | $194.65 | $193.63 | $187.07 | $178.78 | $187.79 | $180.77 | $173.39 | $166.69 | $162.47 |
| Shares outstanding | 217.9M | 220.4M | 221.8M | 225.8M | 225.8M | 227.2M | 231.1M | 233.1M | 233.4M | 234.2M | 235.8M | 236.5M |
| Current ratio | 2.05 | 1.48 | 1.24 | 1.29 | 1.18 | 1.14 | 1.10 | 1.03 | 1.00 | 0.87 | 0.97 | 1.05 |
| Quick ratio | 1.86 | 1.29 | 1.24 | 1.29 | 1.18 | 1.14 | 1.10 | 1.03 | 1.00 | 0.87 | 0.97 | 1.05 |
| Debt / equity | 0.69 | 0.73 | 0.76 | 0.73 | 0.69 | 0.71 | 0.79 | 0.62 | 0.66 | 0.65 | 0.68 | 0.69 |
| Equity / assets | 35.5% | 34.9% | 36.1% | 35.8% | 35.9% | 35.5% | 35.3% | 37.6% | 37.3% | 36.3% | 36.1% | 34.8% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed February 6, 2026); data from EODHD.
ELV financial position
At the end of fiscal 2025 (December 31, 2025), Elevance Health had total assets of $121.5 billion (up 3.9% from a year earlier), total liabilities of $77.5 billion and shareholders' equity of $43.9 billion. It held $9.5 billion in cash and short-term investments against $33.2 billion of debt, net debt of $23.7 billion. Its current ratio was 1.24. In the latest quarter (ended June 30, 2026) total assets were $126.4 billion and equity $44.9 billion.
Related: ELV income statement, ELV cash flow statement, ELV key metrics. See the ELV stock overview for the latest quote and news.
ELV balance sheet FAQ
What are Elevance Health's total assets?
Elevance Health reported total assets of $121.5 billion at the end of fiscal 2025 (December 31, 2025), compared with $116.9 billion a year earlier.
How much debt does Elevance Health have?
Elevance Health had $33.2 billion of total debt at the end of fiscal 2025, including short-term borrowings. Its debt-to-equity ratio was 0.76.
How much cash does Elevance Health have?
Elevance Health held $9.5 billion in cash and short-term investments at the end of fiscal 2025; with $33.2 billion of debt that is net debt of $23.7 billion.
What is Elevance Health's book value?
Elevance Health's shareholders' equity (book value) was $43.9 billion at the end of fiscal 2025, or $197.84 per share.
What is Elevance Health's current ratio?
Elevance Health had current assets of $24.7 billion and current liabilities of $20.0 billion, a current ratio of 1.24 (it can cover its short-term obligations).
How much goodwill does Elevance Health have?
Elevance Health carried $39.5 billion of goodwill and intangible assets, 32.5% of total assets, at the end of fiscal 2025.